Alnylam to Webcast Presentations at Upcoming December Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
Piper Sandler 38th Annual Healthcare Conference on Thursday, December 3, 2026, at 8:30 a.m. ET in
New York City -
Citi’s 2026 Global Healthcare Conference on Thursday, December 3, 2026, at 10:20 a.m. ET in
Miami
A live audio webcast of each presentation will be available on the Investors section of the Company’s website at www.alnylam.com/events. A replay will be posted on the website within 48 hours after each event.
About Alnylam Pharmaceuticals
Alnylam (Nasdaq: ALNY) is a leading global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution. The Company is focused on developing transformative therapies with the potential to prevent, halt, or reverse disease. For more than two decades, Alnylam has advanced the Nobel Prize-winning science of RNAi, delivering critical breakthroughs and seven approved medicines. Alnylam has medicines available in more than 70 countries and a robust and rapidly expanding pipeline, in addition to consistently being recognized as an exceptional workplace and socially responsible organization. The Company is executing its Alnylam 2030 strategy to accelerate innovation and scale impact to transform human health. For more information, visit www.alnylam.com or follow Alnylam on X, LinkedIn, Facebook, Instagram, or YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261120395866/en/
Alnylam Pharmaceuticals, Inc.
Media
media@alnylam.com
Investors
investors@alnylam.com
Source: Alnylam Pharmaceuticals, Inc.